Journal of Cancer Prevention

Korean Society of Cancer Prevention (대한암예방학회)
권호 표지

The Korean Perspective of Helicobacter pylori Infection: Lessons from Japan Policy to Prevent Gastric Cancer

  • Lee, Sooyeon (CHA Cancer Prevention Research Center, CHA Cancer Institute, CHA University) ;
  • Park, Jong-Min (CHA Cancer Prevention Research Center, CHA Cancer Institute, CHA University) ;
  • Park, Sang-Ho (CHA Cancer Prevention Research Center, CHA Cancer Institute, CHA University) ;
  • Kim, Eun-Hee (CHA Cancer Prevention Research Center, CHA Cancer Institute, CHA University) ;
  • Hahm, Ki Baik (CHA Cancer Prevention Research Center, CHA Cancer Institute, CHA University)
  • Published : 2013.06.30
⟨ Previous Next ⟩

Abstract

The guideline of the Korean College of Helicobacter and Upper Gastrointestinal Research group for Helicobacter pylori infection was first produced in 1998. Definite indication for H. pylori eradication is early gastric cancer in addition to the previous indications of peptic ulcer (PUD) including scar lesion and marginal zone B cell lymphoma (MALT type). Though treatment regimen was similar, Japan government declared the inclusion of H. pylori eradication in patients with H. pylori-associated chronic gastritis, suggesting the treatment guideline is quite different between Korea and Japan from February 21, 2013. The prime rationale of Japanese extended treatment guideline for H. pylori infection was based on the drastic intention to prevent gastric cancer according to their beliefs that H. pylori eradication can decrease gastric cancer incidence as well as mortality. In this review, the discrepancy in treatment guideline between Korea and Japan will be explained.

Keywords

References

  1. International Agency for Research on Cancer, World Health Organization. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241.
  2. Asaka M. Helicobacter pylori infection and gastric cancer. Intern Med 2002;41:1-6. https://doi.org/10.2169/internalmedicine.41.1
  3. Asaka M, Kato M, Graham DY. Strategy for eliminating gastric cancer in Japan. Helicobacter 2010;15:486-90. https://doi.org/10.1111/j.1523-5378.2010.00799.x
  4. Asaka M. A new approach for elimination of gastric cancer deaths in Japan. Int J Cancer 2013;132:1272-6. https://doi.org/10.1002/ijc.27965
  5. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917. https://doi.org/10.1002/ijc.25516
  6. Malfertheiner P, Sipponen P, Naumann M, Moayyedi P, Megraud F, Xiao SD, et al. Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Am J Gastroenterol 2005;100:2100-15. https://doi.org/10.1111/j.1572-0241.2005.41688.x
  7. Wu CY, Kuo KN, Wu MS, Chen YJ, Wang CB, Lin JT. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology 2009;137:1641-8.e1-2. https://doi.org/10.1053/j.gastro.2009.07.060
  8. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008;372:392-7. https://doi.org/10.1016/S0140-6736(08)61159-9
  9. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9. https://doi.org/10.1056/NEJMoa001999
  10. Asaka M, Kato M, Takahashi S, Fukuda Y, Sugiyama T, Ota H, et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter 2010;15:1-20.
  11. Lee SY. Future candidates for indications of Helicobacter pylori eradication: do the indications need to be revised? J Gastroenterol Hepatol 2012;27:200-11. https://doi.org/10.1111/j.1440-1746.2011.06961.x
  12. Kim N, Kim JJ, Choe YH, Kim HS, Kim JI, Chung IS. Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea. Korean J Gastroenterol 2009;54:269-78. https://doi.org/10.4166/kjg.2009.54.5.269
  13. Jee SR, Jung HK, Min BH, Choi KD, Rhee PL, Kang YW, et al. Guidelines for the treatment of functional dyspepsia. Korean J Gastroenterol 2011;57:67-81. https://doi.org/10.4166/kjg.2011.57.2.67
  14. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;1:1273-5.
  15. Hahm KB, Lee KM, Kim YB, Hong WS, Lee WH, Han SU, et al. Conditional loss of TGF-beta signalling leads to increased susceptibility to gastrointestinal carcinogenesis in mice. Aliment Pharmacol Ther 2002;16 Suppl 2:115-27.
  16. Han SU, Kim YB, Joo HJ, Hahm KB, Lee WH, Cho YK, et al. Helicobacter pylori infection promotes gastric carcinogenesis in a mice model. J Gastroenterol Hepatol 2002;17:253-61. https://doi.org/10.1046/j.1440-1746.2002.02684.x
  17. Kim YJ, Chung JW, Lee SJ, Choi KS, Kim JH, Hahm KB. Progression from chronic atrophic gastritis to gastric cancer; tangle, toggle, tackle with Korea red ginseng. J Clin-Biochem Nutr 2010;46:195-204. https://doi.org/10.3164/jcbn.10-03
  18. Chung JW, Hahm KB. Rejuvenation of atrophic gastritis in the elderly. J Gastroenterol Hepatol 2010;25:434-5. https://doi.org/10.1111/j.1440-1746.2010.06251.x
  19. Lee JS, Paek NS, Kwon OS, Hahm KB. Anti-inflammatory actions of probiotics through activating suppressor of cytokine signaling (SOCS) expression and signaling in Helicobacter pylori infection: a novel mechanism. J Gastroenterol Hepatol 2010;25:194-202. https://doi.org/10.1111/j.1440-1746.2009.06127.x
  20. Won I, Kim YJ, Kim SJ, Kim EH, Hahm KB. Nutrigenomic approach to tackle the unpleasant journey to Helicobacter pylori-associated gastric carcinogenesis. J Dig Dis 2011;12:157-64. https://doi.org/10.1111/j.1751-2980.2011.00492.x
  21. Lee SY, Shin YW, Hahm KB. Phytoceuticals: mighty but ignored weapons against Helicobacter pylori infection. J Dig Dis 2008;9:129-39. https://doi.org/10.1111/j.1751-2980.2008.00334.x
  22. Park S, Yeo M, Jin JH, Lee KM, Jung JY, Choue R, et al. Rescue of Helicobacter pylori -induced cytotoxicity by red ginseng. Dig Dis Sci 2005;50:1218-27. https://doi.org/10.1007/s10620-005-2763-x
  23. Chun KS, Kim EH, Lee S, Hahm KB. Chemoprevention of gastrointestinal cancer: the reality and the dream. Gut Liver 2013;7:137-49. https://doi.org/10.5009/gnl.2013.7.2.137
  24. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30. https://doi.org/10.3322/caac.21166